Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
08/17/1995 | WO1995021528A1 Targeted cytolysis of hiv-infected cells by chimeric cd4 receptor-bearing cells |
08/17/1995 | WO1995016040A3 Immunofluorescence assay for the detection of antibodies using recombinant antigens in insoluble form |
08/17/1995 | WO1995007994A3 Recombinant alphavirus vectors |
08/17/1995 | DE4421079C1 New chimaeric peptide nucleic acid construct |
08/17/1995 | DE4420782C1 New DNA encoding a 2-oxoglutarate-malate translocator |
08/17/1995 | CA2185683A1 Monoclonal antibodies specific to vegf receptors and uses thereof |
08/17/1995 | CA2183362A1 Mosaic polypeptide and methods for detecting the hepatitis e virus |
08/17/1995 | CA2183266A1 Hematopoietic protein and materials and methods for making it |
08/17/1995 | CA2183260A1 Prolactin as a vaccine adjuvant |
08/17/1995 | CA2183254A1 Mammalian cell cycle protein |
08/17/1995 | CA2183166A1 Heterologous g protein coupled receptors expressed in yeast, their fusion with g proteins and use thereof in bioassay |
08/17/1995 | CA2183154A1 Non-pathogenic strains of hiv-1 |
08/17/1995 | CA2183067A1 Expression of the glucose oxidase gene in transgenic organisms |
08/17/1995 | CA2183066A1 Ligand (act-4-l) to a receptor on the surface of activated cd4+ t-cells |
08/17/1995 | CA2182978A1 Peptides and methods against diabetes |
08/17/1995 | CA2182977A1 Inducing tolerance with tolerogenic fusion proteins |
08/17/1995 | CA2182969A1 Methods for identifying individuals suffering from a cellular abnormality |
08/17/1995 | CA2182967A1 Production and use of map kinase phosphatases and encoding nucleic acid therefor |
08/17/1995 | CA2182778A1 Antifungal proteins, dna coding therefor, and hosts incorporating same |
08/17/1995 | CA2182682A1 Immunointeractive molecules-i |
08/17/1995 | CA2182681A1 An immunointeractive molecule which binds the tie2/tek receptor extracellular domain |
08/17/1995 | CA2182574A1 Mammalian thymokine genes |
08/17/1995 | CA2182494A1 Antibodies which bind the g-csf receptor extracellular domain and methods of treatment |
08/17/1995 | CA2182310A1 Pp32: a newly identified cd45-associated protein |
08/17/1995 | CA2182118A1 Nucleic acid-containing composition, its preparation and use |
08/17/1995 | CA2181803A1 Fk-506 cytosolic binding protein |
08/17/1995 | CA2166313A1 Non-a, non-b, non-c, non-d, non-e hepatitis reagents and methods for their use |
08/17/1995 | CA2160591A1 Protein having tpo activity |
08/16/1995 | EP0667394A2 Recombinant antibody produced by transformed Bacillus bacteria |
08/16/1995 | EP0667393A2 Novel process, construct and conjugate for producing multiple nucleic acid copies |
08/16/1995 | EP0666929A1 Method of inhibiting replication of hyperproliferative cells |
08/16/1995 | EP0666927A1 Nucleic acids extension assay. |
08/16/1995 | EP0666926A1 Nuclear hormone receptor-interacting polypeptides and related molecules and methods |
08/16/1995 | EP0666924A1 Particle transfection: a method for the transfer of polynucleotide molecule into cells |
08/16/1995 | EP0666923A1 Targeted delivery of poly- or oligonucleotides to cells |
08/16/1995 | EP0666922A1 Plants with reduced susceptibility to plant-parasitic nematodes |
08/16/1995 | EP0666921A1 Monocot having dicot wound inducible promoter |
08/16/1995 | EP0666920A1 Thrombin activatable plasminogen derivatives |
08/16/1995 | EP0666919A1 Vaccine containing a thiol protease |
08/16/1995 | EP0666918A1 PRODUCTION OF GAMMA LINOLENIC ACID BY A $g(D)6-DESATURASE |
08/16/1995 | EP0666917A1 M. paratuberculosis promoter and use thereof in immunogenic sequence expression |
08/16/1995 | EP0666916A1 Plasmodium falciparum antigens inducing protective antibodies |
08/16/1995 | EP0666915A1 The pct-65 serotonin receptor |
08/16/1995 | EP0666914A1 Novel p-selectin ligand protein |
08/16/1995 | EP0666913A1 P53 protein fragments and use thereof for detecting and monitoring diseased conditions |
08/16/1995 | EP0666911A1 Multidrug resistance gene |
08/16/1995 | EP0666910A1 Method of cleaving specific strands of rna |
08/16/1995 | EP0666906A1 Cho cells expressing human endothelin receptors |
08/16/1995 | EP0666905A1 Molecules with antibody combining sites that induce asymmetry |
08/16/1995 | EP0666904A1 Attenuated strains of aeromonas salmonicida useful as fish vaccines |
08/16/1995 | EP0666903A1 Insulin-dependent yeast or fungi |
08/16/1995 | EP0666868A1 Vascular endothelial cell growth factor antagonists |
08/16/1995 | EP0666865A1 Plant fatty acid synthases |
08/16/1995 | EP0666760A1 VACCINE COMPRISING PART OF CONSTANT REGION OF IgE FOR TREATMENT OF IgE-MEDIATED ALLERGIC REACTIONS |
08/16/1995 | EP0666755A1 Inhibitiion of retrovirus infection |
08/16/1995 | EP0666751A1 Hepatitis a virus vaccines |
08/16/1995 | EP0605410B1 Immunodiagnostic assay for rheumatoid arthritis |
08/16/1995 | EP0532525B1 New protein-polycation conjugates |
08/16/1995 | EP0527809B1 Walk-through mutagenesis |
08/16/1995 | EP0477284B1 Processes for the recovery of naturally produced chymosin |
08/16/1995 | EP0418308B1 Recombinant techniques for production of novel natriuretic and vasodilator peptides |
08/16/1995 | EP0372071B1 Monoclonal antibodies against lens epithelial cells and methods for preventing proliferation of remnant lens epithelial cells after extracapsular extraction |
08/16/1995 | EP0371999B1 Nucleic acid and methods for the synthesis of novel fusion polypeptides with a phospholipid anchor domain |
08/16/1995 | CN1106862A Synthetic gene of rice ribulose-1,5-diphosphocarboxylase/oxygenase major subunit |
08/15/1995 | US5442052 Expression of genes in transgenic plants |
08/15/1995 | US5442050 Isolated DNA sequences |
08/15/1995 | US5442049 Viricides |
08/15/1995 | US5441934 Dna sequences |
08/15/1995 | US5441889 Incorporated in reccombinant nucleotide sequences and vectors |
08/15/1995 | US5441884 Bacillus thuringiensis transposon TN5401 |
08/15/1995 | US5441883 A3 adenosine receptor, DNA, and uses |
08/15/1995 | US5441882 Method for preparing modified subtilisins |
08/15/1995 | US5441881 Culturing Escherichia transformed with cloning vector; gene expression; useful in genetic engineering |
08/15/1995 | US5441880 Human cdc25 genes, encoded products and uses thereof |
08/15/1995 | US5441870 Methods for monitoring cellular processing of β-amyloid precursor protein |
08/15/1995 | US5441868 Production of recombinant erythropoietin |
08/15/1995 | US5441739 Reduced and controlled surface binding of biologically active molecules |
08/15/1995 | US5441736 Actinobacillus pleuropneumoniae outer membrane lipoprotein A and uses thereof |
08/15/1995 | CA1336693C Recombinant dna vectors encoding a 4"-0-isovaleryl acylase derived from a carbomycin biosynthetic gene, designated care, for use in streptomyces and other organisms |
08/15/1995 | CA1336692C Cloning and expression of the 47-kilodalton antigen of treponema pallidum |
08/15/1995 | CA1336691C Recombinant pseudomonas exotoxin: construction of an active immunotoxin with low side effects |
08/11/1995 | CA2142171A1 Antibody encoding recombinant dna and its use |
08/10/1995 | WO1995021380A1 Assay for screening of receptor antagonists |
08/10/1995 | WO1995021271A1 Ligase/polymerase-mediated genetic bit analysistm of single nucleotide polymorphisms and its use in genetic analysis |
08/10/1995 | WO1995021268A1 High electric field detection of melting temperature polymorphism |
08/10/1995 | WO1995021267A1 Heat-inducible n-degron module |
08/10/1995 | WO1995021263A1 Heterologous dimeric proteins produced in heterokaryons |
08/10/1995 | WO1995021261A1 Recombinant infectious bovine rhinotracheitis virus s-ibr-052 and uses thereof |
08/10/1995 | WO1995021260A1 High expression nucleic acid vectors |
08/10/1995 | WO1995021259A1 Adenoviral-mediated method of cell transfection |
08/10/1995 | WO1995021258A1 Fusion proteins that include antibody and nonantibody portions |
08/10/1995 | WO1995021257A1 Improved production of poly-beta-hydroxyalkanoates in transformed prokaryotic hosts |
08/10/1995 | WO1995021256A1 Msrv1 virus and msrv2 pathogenic and/or infectious agent associated with multiple sclerosis, nucleic acid components and applications of same |
08/10/1995 | WO1995021255A1 Compositions useful in controlling marek's disease |
08/10/1995 | WO1995021254A1 Multivariant il-3 hematopoiesis fusion protein |
08/10/1995 | WO1995021253A1 Ets1 gene: a human tumor suppressor gene |
08/10/1995 | WO1995021252A2 Wd-40-derived peptides and uses thereof |
08/10/1995 | WO1995021251A1 T-cell antigens, and their use in diagnosis and treatment of t-cell mediated conditions |
08/10/1995 | WO1995021250A2 Production of pharmaceutical-grade plasmid dna |
08/10/1995 | WO1995021249A1 A cassette to accumulate multiple proteins through synthesis of a self-processing polypeptide |